- E-mailtorbjorn.krakenes@uib.no
- Visitor AddressHaukeland Universitetssykehus Laboratoriebygget, 7. etg. Heis øst5009 Bergen
- Postal AddressPostboks 78045020 Bergen
- (2024). The Therapeutic Mechanisms of Mesenchymal Stem Cells in MS—A Review Focusing on Neuroprotective Properties. International Journal of Molecular Sciences. 25 pages.
- (2023). The neuroprotective potential of mesenchymal stem cells from bone marrow and human exfoliated deciduous teeth in a murine model of demyelination. PLOS ONE.
- (2023). Development and Optimization of a Multilayer Rat Purkinje Neuron Culture. Cerebellum.
- (2022). Safety and Clinical Efficacy of Mesenchymal Stem Cell Treatment in Traumatic Spinal Cord Injury, Multiple Sclerosis and Ischemic Stroke – A Systematic Review and Meta-Analysis. Frontiers in Neurology.
- (2022). Expression of cerebellar degeneration-related proteins CDR2 and CDR2L in human and rat brain tissue. Journal of Neuroimmunology.
- (2021). Stem cell derived astrocytes with POLG mutations and mitochondrial dysfunction including abnormal NAD+ metabolism is toxic for neurons. bioRxiv.
- (2020). Reply to “CDR2 and CDR2L Yo Antigens in Paraneoplastic Cerebellar Degeneration”. Annals of Neurology. 429.
- (2020). Localization of CDR2L and CDR2 in paraneoplastic cerebellar degeneration. Annals of clinical and translational neurology. 2231-2242.
- (2019). Mitochondrial complex IV is lost in neurons in the cuprizone mouse model. Mitochondrion (Amsterdam. Print). 58-62.
- (2019). CDR2L Is the Major Yo Antibody Target in Paraneoplastic Cerebellar Degeneration. Annals of Neurology. 316-321.
- (2018). Expression of the onconeural protein CDR1 in cerebellum and ovarian cancer. OncoTarget. 23975-23986.
More information in national current research information system (CRIStin)